Clinical Trial Detail

NCT ID NCT02145910
Title Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Thomas Jefferson University
Indications

melanoma

Therapies

Vemurafenib

Age Groups: adult

Additional content available in CKB BOOST